Related Experiment Video
Updated: Mar 25, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.4K
[Global views on clinical trials and data quality].
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|February 26, 2016
Summary
Ensuring clinical trial data quality requires verifying not only analysis accuracy but also data authenticity, integrity, and compliant procedures. This ensures reliable drug efficacy and safety validation through rigorous monitoring and auditing.
Area of Science:
- Clinical Research
- Data Management
- Regulatory Compliance
Background:
- Clinical trial quality and integrity are paramount for drug efficacy and safety validation.
- Data accuracy, authenticity, and integrity are crucial components of reliable clinical trial outcomes.
- Compliance with Good Clinical Practices (GCP) and standards underpins the trustworthiness of trial data and documentation.
Purpose of the Study:
- To emphasize the multifaceted nature of clinical trial quality and integrity.
- To highlight the importance of authentic data and compliant procedures throughout the trial lifecycle.
- To underscore the role of monitoring and auditing in ensuring data reliability and procedural compliance.
Main Methods:
- Review of principles governing clinical trial data quality and integrity.
- Analysis of the impact of data authenticity and procedural compliance on trial outcomes.
- Examination of monitoring and auditing practices in clinical research.
Main Results:
- Clinical trial quality extends beyond data analysis to encompass data authenticity, integrity, and procedural compliance.
- Adherence to Good Clinical Practices (GCP) is fundamental for establishing data reliability and accuracy.
- Effective monitoring and auditing validate both data analytic outcomes and the scientific/compliant execution of trial management.
Conclusions:
- Robust clinical trial quality relies on a holistic approach, integrating data accuracy, authenticity, integrity, and compliant procedures.
- Good Clinical Practices (GCP) compliance is essential for generating convincing evidence of drug safety and efficacy.
- Comprehensive monitoring and auditing are critical for validating the entire clinical trial process, from data collection to analysis.
Related Concept Videos
01:16Clinical Trials
11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.1K
01:11Clinical Trials: Overview
5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
01:13Bioequivalence studies: Biowaivers
382
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
382
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
204
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
204
01:28Preclinical Development: Overview
6.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.4K